Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease

Institute of Medical Microbiology and Department of Cardiovascular Surgery, Medical University of Lubeck, Germany. maass@hygiene.mu-luebeck.de

OBJECTIVES: We sought to examine coronary arteries for the presence of viable bacteria of the fastidious species Chlamydia pneumoniae. BACKGROUND: The respiratory pathogen C. pneumoniae has been implicated in the pathogenesis of coronary artery disease (CAD). Previous studies have demonstrated an antichlamydial seroresponse to be a cardiovascular risk factor and coronary atheromata to contain chlamydial components in varying proportions. Endovascular demonstration of replicating bacteria is required to provide evidence for an infectious component in CAD and a rationale to discuss antimicrobial therapy. METHODS: Myocardial revascularization was performed in 70 patients. Atherosclerotic lesions from 53 coronary endarterectomy and 17 restenotic bypass samples were cultured and subjected to nested polymerase chain reaction (PCR) for C. pneumoniae. Antichlamydial immunoglobulin G (IgG), IgA and IgM was examined by microimmunofluorescence. RESULTS: Viable C. pneumoniae was recovered from 11 (16%) of 70 atheromata, and chlamydial deoxyribonucleic acid (DNA) was detected in 21 (30%) of 70 atheromata; 17 nonatherosclerotic control samples were PCR-negative (p < 0.01). Fifteen (28%) of 53 endarterectomy and 6 (35%) of 17 bypass samples were PCR-positive. DNA sequencing of six different PCR products did not reveal differences between coronary isolates and respiratory reference strains, suggesting that common respiratory strains gain access to the systemic circulation. Serologic results did not correlate with direct detection results and did not identify individual endovascular infection. CONCLUSIONS: A significant proportion of atherosclerotic coronary arteries harbor viable C. pneumoniae. This finding supports the hypothesis of a chlamydial contribution to atherogenesis. Whether chlamydiae initiate atherosclerotic injury, facilitate its progression or colonize atheromata is unknown. However, the endovascular presence of viable bacteria justifies a controlled clinical investigation of antimicrobial treatment benefit in the therapy and prevention of CAD.

This article has been cited by other articles:

				U. Ravnskov and K. S. McCully Vulnerable Plaque Formation from Obstruction of Vasa Vasorum by Homocysteinylated and Oxidized Lipoprotein Aggregates Complexed with Microbial Remnants and LDL Autoantibodies Ann. Clin. Lab. Sci., January 1, 2009; 39(1): 3 - 16. [Abstract] [Full Text] [PDF]

				I. Volanen, K. Kallio, M. Saarinen, M. J. Jarvisalo, R. Vainionpaa, T. Ronnemaa, J. Viikari, J. Marniemi, O. Simell, and O. T. Raitakari Arterial Intima-Media Thickness in 13-Year-Old Adolescents and Previous Antichlamydial Antimicrobial Use: A Retrospective Follow-up Study Pediatrics, September 1, 2008; 122(3): e675 - e681. [Abstract] [Full Text] [PDF]

				B. Schmeck, W. Beermann, P. D. N'Guessan, A. C. Hocke, B. Opitz, J. Eitel, Q. T. Dinh, M. Witzenrath, M. Krull, N. Suttorp, et al. Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells Circ. Res., April 25, 2008; 102(8): 888 - 895. [Abstract] [Full Text] [PDF]

				W. L. Baker and K. A. Couch Azithromycin for the secondary prevention of coronary artery disease: A meta-analysis Am. J. Health Syst. Pharm., April 15, 2007; 64(8): 830 - 836. [Abstract] [Full Text] [PDF]

				M. Krull, P. Bockstaller, F. N. Wuppermann, A. C. Klucken, J. Muhling, B. Schmeck, J. Seybold, C. Walter, M. Maass, S. Rosseau, et al. Mechanisms of Chlamydophila pneumoniae-Mediated GM-CSF Release in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 375 - 382. [Abstract] [Full Text] [PDF]

				I. Volanen, M. J. Jarvisalo, R. Vainionpaa, M. Arffman, K. Kallio, S. Angle, T. Ronnemaa, J. Viikari, J. Marniemi, O. T. Raitakari, et al. Increased Aortic Intima-Media Thickness in 11-Year-Old Healthy Children With Persistent Chlamydia pneumoniae Seropositivity Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 649 - 655. [Abstract] [Full Text] [PDF]

				S. J. Ott, N. E. El Mokhtari, M. Musfeldt, S. Hellmig, S. Freitag, A. Rehman, T. Kuhbacher, S. Nikolaus, P. Namsolleck, M. Blaut, et al. Detection of Diverse Bacterial Signatures in Atherosclerotic Lesions of Patients With Coronary Heart Disease Circulation, February 21, 2006; 113(7): 929 - 937. [Abstract] [Full Text] [PDF]

				X. Yang, D. Coriolan, K. Schultz, D. T. Golenbock, and D. Beasley Toll-Like Receptor 2 Mediates Persistent Chemokine Release by Chlamydia pneumoniae-Infected Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2308 - 2314. [Abstract] [Full Text] [PDF]

				X. Yang, D. Coriolan, V. Murthy, K. Schultz, D. T. Golenbock, and D. Beasley Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1069 - H1076. [Abstract] [Full Text] [PDF]

				M. Cochrane, P. Walker, H. Gibbs, and P. Timms Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque Microbiology, July 1, 2005; 151(7): 2285 - 2290. [Abstract] [Full Text] [PDF]

				I. Volanen, O. T. Raitakari, R. Vainionpaa, M. Arffman, J. Aarnisalo, S. Angle, K. Kallio, and O. Simell Serum Lipid Profiles Poorly Correlate With Chlamydia pneumoniae, Helicobacter pylori, and Cytomegalovirus Seropositivity in Prospectively Followed-Up Healthy Children Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 827 - 832. [Abstract] [Full Text] [PDF]

				J. Rupp, T. Hellwig-Burgel, V. Wobbe, U. Seitzer, E. Brandt, and M. Maass Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo PNAS, March 1, 2005; 102(9): 3447 - 3452. [Abstract] [Full Text] [PDF]

				E. V. Kozarov, B. R. Dorn, C. E. Shelburne, W. A. Dunn Jr, and A. Progulske-Fox Human Atherosclerotic Plaque Contains Viable Invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): e17 - e18. [Full Text] [PDF]

				B. Opitz, S. Forster, A. C. Hocke, M. Maass, B. Schmeck, S. Hippenstiel, N. Suttorp, and M. Krull Nod1-Mediated Endothelial Cell Activation by Chlamydophila pneumoniae Circ. Res., February 18, 2005; 96(3): 319 - 326. [Abstract] [Full Text] [PDF]

				R. Mitusch, J. Luedemann, W. G. Wood, K. Berger, U. Schminke, M. Suter, C. Kessler, U. John, J. Rupp, M. Kentsch, et al. Asymptomatic Carotid Atherosclerosis Is Associated With Circulating Chlamydia pneumoniae DNA in Younger Normotensive Subjects in a General Population Survey Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 386 - 391. [Abstract] [Full Text] [PDF]

				M. M. Ieven and V. Y. Hoymans Involvement of Chlamydia pneumoniae in Atherosclerosis: More Evidence for Lack of Evidence J. Clin. Microbiol., January 1, 2005; 43(1): 19 - 24. [Full Text] [PDF]

				M. J. Zibaeenezhad, A. Amanat, A. Alborzi, and A. Obudi Relation of Chlamydia Pneumoniae Infection to Documented Coronary Artery Disease in Shiraz, Southern Iran Angiology, January 1, 2005; 56(1): 43 - 48. [Abstract] [PDF]

				M. Krull, J. Kramp, T. Petrov, A. C. Klucken, A. C. Hocke, C. Walter, B. Schmeck, J. Seybold, M. Maass, S. Ludwig, et al. Differences in Cell Activation by Chlamydophila pneumoniae and Chlamydia trachomatis Infection in Human Endothelial Cells Infect. Immun., November 1, 2004; 72(11): 6615 - 6621. [Abstract] [Full Text] [PDF]

				B. J. Wells, A. G. Mainous III, and L. M. Dickerson Antibiotics for the Secondary Prevention of Ischemic Heart Disease: A Meta-analysis of Randomized Controlled Trials Arch Intern Med, October 25, 2004; 164(19): 2156 - 2161. [Abstract] [Full Text] [PDF]

				B. Maraha, H. Berg, M. Kerver, S. Kranendonk, J. Hamming, J. Kluytmans, M. Peeters, and A. van der Zee Is the Perceived Association between Chlamydia pneumoniae and Vascular Diseases Biased by Methodology? J. Clin. Microbiol., September 1, 2004; 42(9): 3937 - 3941. [Abstract] [Full Text] [PDF]

				B. Ludewig, P. Krebs, and E. Scandella Immunopathogenesis of atherosclerosis J. Leukoc. Biol., August 1, 2004; 76(2): 300 - 306. [Abstract] [Full Text] [PDF]

				P. T. Alpert New and Emerging Theories of Cardiovascular Disease: Infection and Elevated Iron Biol Res Nurs, July 1, 2004; 6(1): 3 - 10. [Abstract] [PDF]

				J. S. Lindholt, J. Stovring, L. Ostergaard, S. Urbonavicius, E. W. Henneberg, B. Honore, and H. Vorum Serum Antibodies Against Chlamydia pneumoniae Outer Membrane Protein Cross-React With the Heavy Chain of Immunoglobulin in the Wall of Abdominal Aortic Aneurysms Circulation, May 4, 2004; 109(17): 2097 - 2102. [Abstract] [Full Text] [PDF]

				J. Gieffers, G. van Zandbergen, J. Rupp, F. Sayk, S. Kruger, S. Ehlers, W. Solbach, and M. Maass Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature Eur. Respir. J., April 1, 2004; 23(4): 506 - 510. [Abstract] [Full Text] [PDF]

				G. van Zandbergen, J. Gieffers, H. Kothe, J. Rupp, A. Bollinger, E. Aga, M. Klinger, H. Brade, K. Dalhoff, M. Maass, et al. Chlamydia pneumoniae Multiply in Neutrophil Granulocytes and Delay Their Spontaneous Apoptosis J. Immunol., February 1, 2004; 172(3): 1768 - 1776. [Abstract] [Full Text] [PDF]

				O. J de Boer, A. E Becker, and A. C van der Wal T lymphocytes in atherogenesis--functional aspects and antigenic repertoire Cardiovasc Res, October 15, 2003; 60(1): 78 - 86. [Full Text] [PDF]

				V. Y. Hoymans, J. M. Bosmans, L. Van Renterghem, R. Mak, D. Ursi, F. Wuyts, C. J. Vrints, and M. Ieven Importance of Methodology in Determination of Chlamydia pneumoniae Seropositivity in Healthy Subjects and in Patients with Coronary Atherosclerosis J. Clin. Microbiol., September 1, 2003; 41(9): 4049 - 4053. [Abstract] [Full Text] [PDF]

				J. Rupp, H. Kothe, A. Mueller, M. Maass, and K. Dalhoff Imbalanced secretion of IL-1{beta} and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients Eur. Respir. J., August 1, 2003; 22(2): 274 - 279. [Abstract] [Full Text] [PDF]

				B. Kocazeybek Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study J. Med. Microbiol., August 1, 2003; 52(8): 721 - 726. [Abstract] [Full Text] [PDF]

				H. Yamaguchi, H. Friedman, M. Yamamoto, K. Yasuda, and Y. Yamamoto Chlamydia pneumoniae Resists Antibiotics in Lymphocytes Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1972 - 1975. [Abstract] [Full Text] [PDF]

				M. Benagiano, A. Azzurri, A. Ciervo, A. Amedei, C. Tamburini, M. Ferrari, J. L. Telford, C. T. Baldari, S. Romagnani, A. Cassone, et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions PNAS, May 27, 2003; 100(11): 6658 - 6663. [Abstract] [Full Text] [PDF]

				R. Zahn, S. Schneider, B. Frilling, K. Seidl, U. Tebbe, M. Weber, M. Gottwik, E. Altmann, F. Seidel, J. Rox, et al. Antibiotic Therapy After Acute Myocardial Infarction: A Prospective Randomized Study Circulation, March 11, 2003; 107(9): 1253 - 1259. [Abstract] [Full Text] [PDF]

				J. P. Higgins Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials Mayo Clin. Proc., March 1, 2003; 78(3): 321 - 332. [Abstract] [PDF]

				P. Apfalter, O. Assadian, F. Blasi, J. Boman, C. A. Gaydos, M. Kundi, A. Makristathis, M. Nehr, M. L. Rotter, and A. M. Hirschl Reliability of Nested PCR for Detection of Chlamydia pneumoniae DNA in Atheromas: Results from a Multicenter Study Applying Standardized Protocols J. Clin. Microbiol., December 1, 2002; 40(12): 4428 - 4434. [Abstract] [Full Text] [PDF]

				F.-J. Neumann Chlamydia pneumoniae-Atherosclerosis Link: A Sound Concept in Search for Clinical Relevance Circulation, November 5, 2002; 106(19): 2414 - 2416. [Full Text] [PDF]

				J. Gieffers, R. J. Belland, W. Whitmire, S. Ouellette, D. Crane, M. Maass, G. I. Byrne, and H. D. Caldwell Isolation of Chlamydia pneumoniae Clonal Variants by a Focus-Forming Assay Infect. Immun., October 1, 2002; 70(10): 5827 - 5834. [Abstract] [Full Text] [PDF]

				I. W. FONG Infections and their role in atherosclerotic vascular disease J Am Dent Assoc, June 1, 2002; 133(suppl_1): 7S - 13S. [Abstract] [Full Text] [PDF]

				H. Yamaguchi, S. Haranaga, R. Widen, H. Friedman, and Y. Yamamoto Chlamydia pneumoniae Infection Induces Differentiation of Monocytes into Macrophages Infect. Immun., May 1, 2002; 70(5): 2392 - 2398. [Abstract] [Full Text] [PDF]

				L. Wilhelmsen Inflammation, infection, and coronary heart disease Eur. Heart J., March 1, 2002; 23(5): 343 - 344. [Full Text] [PDF]

				R. Tavendale, D. Parratt, S.D. Pringle, R. A'brook, and H. Tunstall-Pedoe Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events. The Scottish Heart Health Study Cohort Eur. Heart J., February 2, 2002; 23(4): 301 - 307. [Abstract] [Full Text] [PDF]

				M. L. C. Tondella, D. F. Talkington, B. P. Holloway, S. F. Dowell, K. Cowley, M. Soriano-Gabarro, M. S. Elkind, and B. S. Fields Development and Evaluation of Real-Time PCR-Based Fluorescence Assays for Detection of Chlamydiapneumoniae J. Clin. Microbiol., February 1, 2002; 40(2): 575 - 583. [Abstract] [Full Text] [PDF]

				S. Levenstein Commentary: Peptic ulcer and its discontents Int. J. Epidemiol., February 1, 2002; 31(1): 29 - 33. [Full Text] [PDF]

				J. Boman and M. R. Hammerschlag Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20. [Abstract] [Full Text]

				D. Theegarten, O. Anhenn, S. Aretz, M. Maass, and G. Mogilevski Detection of Chlamydia pneumoniae in unexplained pulmonary hypertension Eur. Respir. J., January 1, 2002; 19(1): 192 - 194. [Abstract] [Full Text] [PDF]

				S. C. Johnston, L. M. Messina, W. S. Browner, M. T. Lawton, C. Morris, and D. Dean C-Reactive Protein Levels and Viable Chlamydia pneumoniae in Carotid Artery Atherosclerosis Stroke, December 1, 2001; 32(12): 2748 - 2752. [Abstract] [Full Text] [PDF]

				P. U. Heuschmann, D. Neureiter, M. Gesslein, B. Craiovan, M. Maass, G. Faller, G. Beck, B. Neundoerfer, and P. L. Kolominsky-Rabas Association Between Infection With Helicobacter pylori and Chlamydia pneumoniae and Risk of Ischemic Stroke Subtypes: Results From a Population-Based Case-Control Study Stroke, October 1, 2001; 32(10): 2253 - 2258. [Abstract] [Full Text] [PDF]

				Y. Momiyama, R. Hirano, H. Taniguchi, H. Nakamura, and F. Ohsuzu Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection J. Am. Coll. Cardiol., September 1, 2001; 38(3): 712 - 717. [Abstract] [Full Text] [PDF]

				A. Schumacher, A. B. Lerkerød, I. Seljeflot, L. Sommervoll, I. Holme, J. E. Otterstad, and H. Arnesen Chlamydia pneumoniae Serology: Importance of Methodology in Patients with Coronary Heart Disease and Healthy Individuals J. Clin. Microbiol., May 1, 2001; 39(5): 1859 - 1864. [Abstract] [Full Text]

				M. VALASSINA, L. MIGLIORINI, A. SANSONI, G. SANI, D. CORSARO, M. G. CUSI, P. E. VALENSIN, and C. CELLESI Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries J. Med. Microbiol., March 1, 2001; 50(3): 228 - 232. [Abstract] [Full Text] [PDF]

				S. R. Goth and R. S. Stephens Rapid, Transient Phosphatidylserine Externalization Induced in Host Cells by Infection with Chlamydia spp. Infect. Immun., February 1, 2001; 69(2): 1109 - 1119. [Abstract] [Full Text] [PDF]

				A Meijer, P J M Roholl, S K Gielis-Proper, and J M Ossewaarde Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions J. Clin. Pathol., December 1, 2000; 53(12): 911 - 916. [Abstract] [Full Text] [PDF]

				S A Morre, W Stooker, W K Lagrand, A J C van den Brule, and H W M Niessen Microorganisms in the aetiology of atherosclerosis J. Clin. Pathol., September 1, 2000; 53(9): 647 - 654. [Abstract] [Full Text] [PDF]

				I. W. Fong Emerging relations between infectious diseases and coronary artery disease and atherosclerosis Can. Med. Assoc. J., July 1, 2000; 163(1): 49 - 56. [Abstract] [Full Text] [PDF]

				J. B. Mahony, S. Chong, B. K. Coombes, M. Smieja, and A. Petrich Analytical Sensitivity, Reproducibility of Results, and Clinical Performance of Five PCR Assays for Detecting Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells J. Clin. Microbiol., July 1, 2000; 38(7): 2622 - 2627. [Abstract] [Full Text]

				A.J. Camm and K.M. Fox Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence? Eur. Heart J., July 1, 2000; 21(13): 1046 - 1051. [PDF]

				J. Rodel, M. Woytas, A. Groh, K.-H. Schmidt, M. Hartmann, M. Lehmann, and E. Straube Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniae Infect. Immun., June 1, 2000; 68(6): 3635 - 3641. [Abstract] [Full Text] [PDF]

				T. J. Bodetti and P. Timms Detection of Chlamydia pneumoniae DNA and Antigen in the Circulating Mononuclear Cell Fractions of Humans and Koalas Infect. Immun., May 1, 2000; 68(5): 2744 - 2747. [Abstract] [Full Text] [PDF]

				H. Kothe, K. Dalhoff, J. Rupp, A. Muller, J. Kreuzer, M. Maass, and H. A. Katus Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors Modify the Inflammatory Response of Human Macrophages and Endothelial Cells Infected With Chlamydia pneumoniae Circulation, April 18, 2000; 101(15): 1760 - 1763. [Abstract] [Full Text] [PDF]

				J. Gieffers, E. Reusche, W. Solbach, and M. Maass Failure To Detect Chlamydia pneumoniae in Brain Sections of Alzheimer's Disease Patients J. Clin. Microbiol., February 1, 2000; 38(2): 881 - 882. [Abstract] [Full Text]

				C. Bartels, M. Maass, G. Bein, N. Brill, J. F. M. Bechtel, R. Leyh, and H.-H. Sievers Association of Serology With the Endovascular Presence of Chlamydia pneumoniae and Cytomegalovirus in Coronary Artery and Vein Graft Disease Circulation, January 18, 2000; 101(2): 137 - 141. [Abstract] [Full Text] [PDF]

				A. Hoffmeister, D. Rothenbacher, P. Wanner, G. Bode, K. Persson, H. Brenner, V. Hombach, and W. Koenig Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: Negative results of a case-control study J. Am. Coll. Cardiol., January 1, 2000; 35(1): 112 - 118. [Abstract] [Full Text] [PDF]

				J. Boman, C. A. Gaydos, and T. C. Quinn Molecular Diagnosis of Chlamydia pneumoniae Infection J. Clin. Microbiol., December 1, 1999; 37(12): 3791 - 3799. [Full Text]

				A. Shor and J. I. Phillips Chlamydia pneumoniae and Atherosclerosis JAMA, December 1, 1999; 282(21): 2071 - 2073. [Full Text] [PDF]

				I. W. Fong, B. Chiu, E. Viira, D. Jang, M. W. Fong, R. Peeling, and J. B. Mahony Can an Antibiotic (Macrolide) Prevent Chlamydia pneumoniae-Induced Atherosclerosis in a Rabbit Model? Clin. Vaccine Immunol., November 1, 1999; 6(6): 891 - 894. [Abstract] [Full Text] [PDF]

				I. W. Fong, B. Chiu, E. Viira, D. Jang, and J. B. Mahony De Novo Induction of Atherosclerosis by Chlamydia pneumoniae in a Rabbit Model Infect. Immun., November 1, 1999; 67(11): 6048 - 6055. [Abstract] [Full Text] [PDF]

				Y.-k. Wong, K. D. Dawkins, and M. E. Ward Circulating chlamydia pneumoniae DNA as a predictor of coronary artery disease J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1435 - 1439. [Abstract] [Full Text] [PDF]

				A. Meijer, J. A. van der Vliet, P. J. M. Roholl, S. K. Gielis-Proper, A. de Vries, and J. M. Ossewaarde Chlamydia pneumoniae in Abdominal Aortic Aneurysms : Abundance of Membrane Components in the Absence of Heat Shock Protein 60 and DNA Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2680 - 2686. [Abstract] [Full Text] [PDF]

				R. Dechend, M. Maass, J. Gieffers, R. Dietz, C. Scheidereit, A. Leutz, and D. C. Gulba Chlamydia pneumoniae Infection of Vascular Smooth Muscle and Endothelial Cells Activates NF-{kappa}B and Induces Tissue Factor and PAI-1 Expression : A Potential Link to Accelerated Arteriosclerosis Circulation, September 28, 1999; 100(13): 1369 - 1373. [Abstract] [Full Text] [PDF]

				J. T. Grayston Does Chlamydia pneumoniae Cause Atherosclerosis? Arch Surg, September 1, 1999; 134(9): 930 - 934. [Full Text] [PDF]

				A. Meijer, S. A. Morré, A. J. C. Van Den Brule, P. H. M. Savelkoul, and J. M. Ossewaarde Genomic Relatedness of Chlamydia Isolates Determined by Amplified Fragment Length Polymorphism Analysis J. Bacteriol., August 1, 1999; 181(15): 4469 - 4475. [Abstract] [Full Text]

				M. Thomas, Y. Wong, D. Thomas, M. Ajaz, V. Tsang, P. J. Gallagher, and M. E. Ward Relation Between Direct Detection of Chlamydia pneumoniae DNA in Human Coronary Arteries at Postmortem Examination and Histological Severity (Stary Grading) of Associated Atherosclerotic Plaque Circulation, June 1, 1999; 99(21): 2733 - 2736. [Abstract] [Full Text] [PDF]

				D. P Strachan, D. Carrington, M. A Mendall, L. Ballam, J. Morris, B. K Butland, P. M Sweetnam, P. C Elwood, and R. R West Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study • Commentary: Chlamydia pneumoniae infection and ischaemic heart disease BMJ, April 17, 1999; 318(7190): 1035 - 1040. [Abstract] [Full Text]

				A. Tiran, R. A. Tio, J. M. Ossewaarde, B. Tiran, P. den Heijer, T. H. The, and M. M. Wilders-Truschnig Coronary Angioplasty Induces Rise in Chlamydia pneumoniae-Specific Antibodies J. Clin. Microbiol., April 1, 1999; 37(4): 1013 - 1017. [Abstract] [Full Text]

				J. T. Grayston Antibiotic Treatment Trials for Secondary Prevention of Coronary Artery Disease Events Circulation, March 30, 1999; 99(12): 1538 - 1539. [Full Text] [PDF]

				R. E. Molestina, R. D. Miller, J. A. Ramirez, and J. T. Summersgill Infection of Human Endothelial Cells with Chlamydia pneumoniae Stimulates Transendothelial Migration of Neutrophils and Monocytes Infect. Immun., March 1, 1999; 67(3): 1323 - 1330. [Abstract] [Full Text] [PDF]

				Y-K Wong, P J Gallagher, and M E Ward Chlamydia pneumoniae and atherosclerosis Heart, March 1, 1999; 81(3): 232 - 238. [Abstract] [Full Text]

				K. Bachmaier, N. Neu, L. M. de la Maza, S. Pal, A. Hessel, and J. M. Penninger Chlamydia Infections and Heart Disease Linked Through Antigenic Mimicry Science, February 26, 1999; 283(5406): 1335 - 1339. [Abstract] [Full Text]

				C. Bartels, M. Maass, G. Bein, R. Malisius, N. Brill, J. F. M. Bechtel, F. Sayk, A. C. Feller, and H.-H. Sievers Detection of Chlamydia pneumoniae But Not Cytomegalovirus in Occluded Saphenous Vein Coronary Artery Bypass Grafts Circulation, February 23, 1999; 99(7): 879 - 882. [Abstract] [Full Text] [PDF]

				G. Caligiuri, G. Liuzzo, L. M. Biasucci, and A. Maseri Immune system activation follows inflammation in unstable angina: pathogenetic implications J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1295 - 1304. [Abstract] [Full Text] [PDF]

				J. Gieffers, W. Solbach, and M. Maass In Vitro Susceptibilities of Chlamydia pneumoniae Strains Recovered from Atherosclerotic Coronary Arteries Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2762 - 2764. [Abstract] [Full Text]